Clinical Trial Update: Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing adherence to Premarin versus Vagifem after female pelvic reconstructive surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Pelvic Floor Disorders

Drugs mentioned

• PREMARIN (Conjugated estrogens)
• Vagifem (Estradiol)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Estrogen, Menopause | Phase 4 | Status: WITHDRAWN